EGFR and hepatocellular carcinoma: We divided the HCC patients into two groups, lnc-EGFRhigh and lnc-EGFRlow, according to the level of lnc-EGFR expressed, using the upper 95% confidence interval (CI) for the peripheral blood CD4+ T cells of the volunteers as the cutoff.